ADPT CapEx to Revenue

Adaptive Biotechnologies Corp · CapEx to Revenue

ADPT logo

ADPT CapEx to Revenue

Current (TTM)0.98%
ADPT CapEx/Revenue (6.52% → 0.98%)
High-resolution chart · PNG

ADPT capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Adaptive Biotechnologies Corp CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
1.0683%
2.0474%
6.2822%
8.8226%
40.0054%
19.1122%
13.1655%
11.3504%
6.5179%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.